Because Fair Medicine wants to introduce a new business model for the pharmaceutical industry, we try to analyse the costs of making medicines the classical way. A report of Gupta Strategists, gives more insights.

FM researcher Simon van der Schans pleads for more transparency when it comes to drugs prices. ‘The cost structure in the pharmaceutical sector is much too complex.’

Frans-Joseph Sinjorgo (59) is the leader of Fair Medicine’s Rediscovery project, which aims to use the active ingredients from ‘older’ drugs to develop new applications.

Working together to make good medicines for a fair price

Fair Medicine produces medicines according to a new business model, in which transparency and affordability come first. According to Cees Smit, author of ‘The Power of the Patient’, Fair Medicine can function as a ‘lever’.

Fair Medicine produces medicines according to a new business model, in which transparency and affordability come first.. Professor Carla Hollak thinks it is ‘a great thing’ that Fair Medicine gives physicians more influence.

Fair Medicine produces medicines according to a new business model, in which transparency and affordability come first. Fair Medicine founder Hans Büller thinks that physicians, patients and social investors ‘should work together’. 

Fair Medicine produces medicines according to a new business model, in which transparency and affordability come first. Biologist Frans de Loos thinks is highly urgent that the ‘pharmaceutical industry gets a new stimulus’